Dechra Pharmaceuticals PLC Annual Report 2008

Printable Logo
 

Consolidated Income Statement

For the year ended 30 June 2008

2008 2007
Note Adjusted £’000 Amortisation
of acquired
intangibles and
rationalisation
costs (note 5)
£’000
Total £’000 Adjusted £’000 Amortisation
of acquired
intangibles and
rationalisation
costs (note 5)
£’000
Total £’000
Revenue 2 304,371 304,371 253,803 253,803
Cost of sales (250,771) (250,771) (216,952) (216,952)
Gross profit 53,600 53,600 36,851 36,851
Distribution costs (13,360) (13,360) (10,850) (10,850)
Administrative expenses (21,098) (5,071) (26,169) (12,125) (27) (12,152)
Operating profit 2 19,142 (5,071) 14,071 13,876 (27) 13,849
Finance income 3 1,973 1,973 1,044 1,044
Finance expense 4 (4,262) (77) (4,339) (2,274) (2,274)
Profit before taxation 6 16,853 (5,148) 11,705 12,646 (27) 12,619
Income tax expense 8 (4,668) 1,281 (3,387) (3,780) 8 (3,772)
Profit for the year attributable to equity holders of the parent


12,185



(3,867)



8,318



8,866



(19)



8,847
Earnings per share
Basic 10 14.20p 16.86p
Diluted 10 14.09p 16.62p
Dividend per share (interim paid and final proposed for the year)


9



8.25p



7.50p

Content | Menu | Top